Sfoglia per Autore
Exploring the landscape of steatotic liver disease in the general US population
2023 Ciardullo, S; Carbone, M; Invernizzi, P; Perseghin, G
Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581, (S0168827821003342), (10.1016/j.jhep.2021.04.055)]
2023 Cordell, H; Fryett, J; Ueno, K; Darlay, R; Aiba, Y; Hitomi, Y; Kawashima, M; Nishida, N; Khor, S; Gervais, O; Kawai, Y; Nagasaki, M; Tokunaga, K; Tang, R; Shi, Y; Li, Z; Juran, B; Atkinson, E; Gerussi, A; Carbone, M; Asselta, R; Cheung, A; de Andrade, M; Baras, A; Horowitz, J; Ferreira, M; Sun, D; Jones, D; Flack, S; Spicer, A; Mulcahy, V; Byan, J; Han, Y; Sandford, R; Lazaridis, K; Amos, C; Hirschfield, G; Seldin, M; Invernizzi, P; Siminovitch, K; Ma, X; Nakamura, M; Mells, G
Authors' reply to Zou et al
2023 Ciardullo, S; Carbone, M; Invernizzi, P; Perseghin, G
Risk stratification in primary sclerosing cholangitis
2023 Mulinacci, G; Cristoferi, L; Palermo, A; Lucà, M; Gerussi, A; Invernizzi, P; Carbone, M
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis
2023 Cristoferi, L; Porta, M; Bernasconi, D; Leonardi, F; Gerussi, A; Mulinacci, G; Palermo, A; Gallo, C; Scaravaglio, M; Stucchi, E; Maino, C; Ippolito, D; D'Amato, D; Ferreira, C; Nardi, A; Banerjee, R; Valsecchi, M; Antolini, L; Corso, R; Sironi, S; Fagiuoli, S; Invernizzi, P; Carbone, M
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe
2023 Murillo Perez, C; Gerussi, A; Trivedi, P; Corpechot, C; Van Der Meer, A; Maria Battezzati, P; Lindor, K; Nevens, F; Kowdley, K; Bruns, T; Cazzagon, N; Floreani, A; Tanaka, A; Ma, X; Mason, A; Gulamhusein, A; Ponsioen, C; Carbone, M; Lleo, A; Mayo, M; Dalekos, G; Gatselis, N; Thorburn, D; Verhelst, X; Pares, A; Janssen, H; Hirschfield, G; Hansen, B; Invernizzi, P; Lammers, W
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis
2023 Christine Halma, J; Cristoferi, L; Carbone, M
Endocrinology and Metabolic Diseases (Including Diabetes)
2023 Cristoferi, L; Ciardullo, S; Invernizzi, P; Perseghin, G; Carbone, M
Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States
2023 Ciardullo, S; Carbone, M; Invernizzi, P; Perseghin, G
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis
2022 Cristoferi, L; Porta, M; Bernasconi, D; Leonardi, F; Gerussi, A; Mulinacci, G; Palermo, A; Gallo, C; Scaravaglio, M; Stucchi, E; Maino, C; Ippolito, D; D'Amato, D; Ferreira, C; Nardi, A; Banerjee, R; Valsecchi, M; Antolini, L; Corso, R; Sironi, S; Fagiuoli, S; Invernizzi, P; Carbone, M
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis
2022 Corpechot, C; Carrat, F; Gaouar, F; Chau, F; Hirschfield, G; Gulamhusein, A; Montano-Loza, A; Lytvyak, E; Schramm, C; Pares, A; Olivas, I; Eaton, J; Osman, K; Dalekos, G; Gatselis, N; Nevens, F; Cazzagon, N; Zago, A; Russo, F; Abbas, N; Trivedi, P; Thorburn, D; Saffioti, F; Barkai, L; Roccarina, D; Calvaruso, V; Fichera, A; Delamarre, A; Medina-Morales, E; Bonder, A; Patwardhan, V; Rigamonti, C; Carbone, M; Invernizzi, P; Cristoferi, L; van der Meer, A; de Veer, R; Zigmond, E; Yehezkel, E; Kremer, A; Deibel, A; Dumortier, J; Bruns, T; Große, K; Pageaux, G; Wetten, A; Dyson, J; Jones, D; Chazouillères, O; Hansen, B; de Lédinghen, V
Artificial intelligence for precision medicine in autoimmune liver disease
2022 Gerussi, A; Scaravaglio, M; Cristoferi, L; Verda, D; Milani, C; De Bernardi, E; Ippolito, D; Asselta, R; Invernizzi, P; Kather, J; Carbone, M
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis
2022 Overi, D; Carpino, G; Cristoferi, L; Onori, P; Kennedy, L; Francis, H; Zucchini, N; Rigamonti, C; Vigano, M; Floreani, A; D'Amato, D; Gerussi, A; Venere, R; Alpini, G; Glaser, S; Alvaro, D; Invernizzi, P; Gaudio, E; Cardinale, V; Carbone, M
Machine learning in primary biliary cholangitis: A novel approach for risk stratification
2022 Gerussi, A; Verda, D; Bernasconi, D; Carbone, M; Komori, A; Abe, M; Inao, M; Namisaki, T; Mochida, S; Yoshiji, H; Hirschfield, G; Lindor, K; Pares, A; Corpechot, C; Cazzagon, N; Floreani, A; Marzioni, M; Alvaro, D; Vespasiani‐gentilucci, U; Cristoferi, L; Valsecchi, M; Muselli, M; Hansen, B; Tanaka, A; Invernizzi, P
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature
2022 Gemelli, M; Carbone, M; Abbate, M; Mancin, M; Zucchini, N; Colonese, F; Invernizzi, P; Bidoli, P; Cortinovis, D
The application of artificial intelligence in hepatology: A systematic review
2022 Balsano, C; Alisi, A; Brunetto, M; Invernizzi, P; Burra, P; Piscaglia, F; Alvaro, D; Bonino, F; Carbone, M; Faita, F; Gerussi, A; Persico, M; Santini, S; Zanetto, A
Hepatitis C virus infection and diabetes: a complex bidirectional relationship
2022 Ciardullo, S; Mantovani, A; Ciaccio, A; Carbone, M; Invernizzi, P; Perseghin, G
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis
2022 Gerussi, A; Verda, D; Cappadona, C; Cristoferi, L; Bernasconi, D; Bottaro, S; Carbone, M; Muselli, M; Invernizzi, P; Asselta, R
An update on novel pharmacological agents for primary sclerosing cholangitis
2022 Gallo, C; Howardson, B; Cristoferi, L; Carbone, M; Gershwin, M; Invernizzi, P
Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents
2022 Ciardullo, S; Carbone, M; Invernizzi, P; Perseghin, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile